Hurriyet.com.tr/INTERNATIONAL NEWS
The expected good news about the Omicron variant, which caused alarm around the world, came from the BioNTech company owned by Özlem Türeci and Uğur Şahin. A statement for the ‘Omicron vaccine’ developed by BioNTech and Pfizer came from the European Medicines Agency today. In the statement made by the agency, it was stated that the vaccine is planned to be approved by autumn.
The world has been fighting for two years coronavirus While preparing to breathe a full sigh of relief in the epidemic, Omciron’s sub-variant BA.4 and BA.5 caused the number of cases to rise again and the countries to be on alert.
The World Health Organization (WHO) monitored sub-variants BA.4 and BA.5 in April. Two sub-variants have now become dominant across the US and Europe.
EXPECTED NEWS AGAIN BIONTECHFROM
The expected news for the variant, which experts describe as the most contagious variant ever, came from BioNTech, owned by Özlem Türeci and Uğur Şahin.
BioNTech and Pfizeradapted to Omicron’s BA.4 and BA.5 variants Covid-19 announced that the clinical trial of the vaccine will begin this month. In the company’s statement, it was stated that the vaccine, which was developed to provide long and wide protection, could go on sale at the end of this year.
STATEMENT FROM EMA: WE ARE PLANNING TO APPROVE BY FALLclass=”medianet-inline-adv”>
The European Medicines Agency (EMA) announced that review of the Pfizer vaccine began Monday, which targets two subvariants that are more contagious than previous variants and have managed to evade immunity.
The EMA spokesperson said in a statement on the subject today that the vaccine is planned to be approved quickly by autumn.
EMA, which oversees drugs for the 27-nation European Union, is also testing US manufacturer Moderna’s vaccine adapted for Omicron, which is based on mRNA technology, such as BioNTech/Pfizer’s vaccine.
In a previous statement from the agency, it had said that adapted vaccines for Omicron could be approved as early as September.
ESCAPE FROM VACCINE AND NATURAL IMMUNITY
After the rapid spread of the Omicron variant, the scientists discovered that the BA.4 and BA.5 sub-variants were able to evade both vaccine and natural immunity.
class=”medianet-inline-adv”>
British Professor Tim Spector, who conducted the research called ‘Zoe Covid Symptoms’, stated that people with complaints of fatigue and sore throat, which are two common symptoms of the last period, should be tested urgently. “Even if people have had an infection in the past and are fully vaccinated, they can still get the virus. So everyone should continue to follow the pandemic guidelines.” said.
WHO: THE EPIDEMIC IS NOT ENDED
The World Health Organization (WHO) also announced in July that the coronavirus still remains a global health emergency after two and a half years.
WHO noting the rapid spread of sub-variants of Omciron‘The coronavirus epidemic did not end anywhere’ He urged people to be more careful about it.
class=”medianet-inline-adv”>
THIS VIDEO MAY BE INTERESTED
.